Product Information
GS MUCUS ER 600 MG TABLET is a generic product labeled by L. Perrigo Company, priced at $0.2840 per EA under NDC 00113202358. Its NADAC has been published 58 times since Aug 27, 2025.
FDA first approved this application on Nov 23, 2011.
Strength
600 mg/1
Manufacturer
L. Perrigo CompanyNDC
00113202358
Classification
Generic
Dosage Form
TABLET, MULTILAYER, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA078912FDA Approved
11/23/2011
On Market Since
7/4/2020
Pharmacological Classes
Price Statistics
The NADAC for GS MUCUS ER 600 MG TABLET has been published 58 times since Aug 27, 2025, and over the history we have for it it has declined 15.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2840 per EA |
|---|---|
| All-time high | $0.3341 (Sep 10, 2025) |
| All-time low | $0.2840 (Sep 23, 2026) |
| 52-week high | $0.3211 |
| 52-week low | $0.2840 |
| Median price | $0.2995 |
| Average price | $0.3017 |
| Largest weekly change | -4.4% (Sep 17, 2025) |
| Weeks tracked | 58 |
| Tracking since | Aug 27, 2025 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
L. Perrigo Company manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
guaifenesin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GS MUCUS ER 600 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for GS MUCUS ER 600 MG TABLET, manufactured by L. Perrigo Company, is $0.2840 per EA (NDC 00113202358), effective Sep 30, 2026.
How has the price of GS MUCUS ER 600 MG TABLET changed over time?
Over the history we have for it, the NADAC for GS MUCUS ER 600 MG TABLET has declined 15.0%. It has been tracked across 58 weekly CMS publications since Aug 27, 2025.
What are the highest and lowest recorded NADAC prices for GS MUCUS ER 600 MG TABLET?
Since Aug 27, 2025, the NADAC for GS MUCUS ER 600 MG TABLET has ranged from a low of $0.2840 (Sep 23, 2026) to a high of $0.3341 (Sep 10, 2025), with a median of $0.2995 per EA.
Are there cheaper alternatives to GS MUCUS ER 600 MG TABLET?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as GS MUCUS ER 600 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures GS MUCUS ER 600 MG TABLET?
GS MUCUS ER 600 MG TABLET (NDC 00113202358) is labeled by L. Perrigo Company, and CMS classifies it as a generic product.